The effect of disulfiram on the carcinogenicity of N-butyl-N-(3-carboxypropyl)nitrosamine in the rat
- 1 January 1983
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 4 (5) , 617-620
- https://doi.org/10.1093/carcin/4.5.617
Abstract
N-Butyl-N-(3-carboxypropyl)nitrosamine (BCPN) is a proximate carcinogenic metabolite of the bladder specific carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine (BHBN). The objective of this study was to determine if disulfiram would inhibit the induction of bladder cancer in rats given BCPN, as reported for BHBN ( Cancer Res ., 39, 3040, 1979). Two groups of 30 male Wistar rats were given 1.5 mM BCPN (0.028%) in the drinking water for 12 weeks. The total dose of BCPN/rat was 5 mmol (0.95 g). During administration of the BCPN, one group of rats was fed a diet containing 0.5% disulfiram, while the other group was maintained on control diet. At the end of 12 weeks, the animals were maintained on control diet without BCPN for an additional 18 weeks, at which time the animals were sacrificed. It was found that 0.5% disulfiram significantly reduced the incidence of bladder cancer, decreasing from 30/30 (100%) in the group receiving BCPN alone to 3/30 (10%) in the group fed the disulfiram diet. The inhibition of BHBN-induced bladder cancer by disulfiram, previously reported, was also confirmed in these experiments.This publication has 11 references indexed in Scilit:
- The cellular features of developing carcinoma in murine urinary bladderCancer, 1981
- The effect of disulfiram on the carcinogenicity of 3,2' dimethyl-4-aminobiphenyl in Syrian golden hamsters and ratsCarcinogenesis: Integrative Cancer Research, 1981
- Inhibitory Effect of Disulfiram on Rat Mammary Tumor Induction By N-2-Fluorenylacetamide and on its Metabolic Conversion To N-Hydroxy-N-2-fluorenylacetamide2JNCI Journal of the National Cancer Institute, 1980
- γ-Glutamyltransferase and the Inhibition of Azo Dye-Produced Neoplasia by Concomitant Administration of Disulfiram23JNCI Journal of the National Cancer Institute, 1980
- METABOLIC-FATE OF N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE IN THE RAT1980
- INHIBITION OF N-N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE-INDUCED URINARY-BLADDER CANCER IN RATS BY ADMINISTRATION OF DISULFIRAM IN THE DIET1979
- INDUCTION OF TUMORS IN HETEROTOPIC BLADDER BY TOPICAL APPLICATION OF N-METHYL-N-NITROSOUREA AND N-BUTYL-N-(3-CARBOXYPROPYL)NITROSAMINE1978
- Syntheses of N-alkyl-N-(.OMEGA.-carboxyalkyl)nitrosamines related to N-butyl-N-(3-carboxypropyl)nitrosamine, principal urinary metabolite of a potent bladder carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine.CHEMICAL & PHARMACEUTICAL BULLETIN, 1978
- Effects of disulfiram and related compounds on the metabolism in vivo of the colon carcinogen, 1,2-dimethylhydrazineBiochemical Pharmacology, 1977
- Influence of disulfiram on the organotropy of the carcinogenic effect of dimethylnitrosamine and diethylnitrosamine in ratsZeitschrift für Krebsforschung und Klinische Onkologie, 1976